recent
advanc
metagenom
field
huge
effect
identif
character
newli
emerg
viral
pathogen
allow
time
effici
respons
futur
viral
threat
integr
multidisciplinari
approach
util
expertis
sever
area
includ
clinic
assess
viru
surveil
viru
discoveri
pathogenesi
molecular
basi
host
respons
infect
requir
requir
scientif
commun
involv
viru
discoveri
go
one
step
beyond
initi
decreas
industri
countri
first
half
last
centuri
burden
infecti
diseas
human
health
worldwid
markedli
increas
past
decad
complex
mix
predispos
factor
modern
world
creat
new
opportun
emerg
infecti
diseas
anim
human
alik
larg
relat
global
environment
anthropogen
chang
chang
natur
contact
anim
human
emerg
event
human
caus
virus
origin
anim
world
follow
initi
zoonot
transmiss
virus
usual
go
period
adapt
new
human
host
may
spread
caus
epidem
eventu
true
pandem
devast
exampl
pandem
caus
initi
zoonot
virus
acquir
immunodefici
syndrom
aid
pandem
caus
human
immunodefici
viru
hiv
spill
chimpanze
reservoir
spanish
influenza
spill
bird
reservoir
exampl
sever
acut
respiratori
syndrom
sar
coronaviru
bat
civet
cat
swine
influenza
viru
nipah
viru
bat
pig
human
mortal
figur
associ
emerg
viral
diseas
rang
hundr
limit
epidem
mani
million
pandem
exampl
ongo
aid
pandem
caus
death
ten
million
peopl
wherea
sar
appar
spill
bat
reservoir
caus
start
pandem
could
first
time
histori
halt
one
thousand
peopl
die
major
impact
newli
emerg
reemerg
viru
infect
also
seen
anim
wildlif
pose
direct
threat
biodivers
domest
anim
caus
huge
loss
livestock
product
latter
may
due
direct
mortal
cull
strategi
diseas
control
light
import
creat
well
coordin
global
effort
monitor
viral
pathogen
gain
thorough
understand
divers
virus
anim
human
viru
transmiss
rout
viru
tropism
provid
inform
potenti
pathogen
threat
anim
reservoir
human
health
thu
integr
multidisciplinari
approach
util
expertis
sever
area
includ
clinic
assess
viru
surveil
viru
discoveri
viru
divers
evolutionari
process
epidemiolog
pathogenesi
molecular
basi
host
respons
infect
requir
understand
dynam
infect
mitig
potenti
effect
futur
infecti
threat
figur
one
overlook
crucial
aspect
identifi
new
infecti
diseas
threat
role
clinician
veterinarian
epidemiologist
play
recognit
idiopath
case
newli
emerg
viru
infect
profession
first
recogn
rel
uncommon
complet
new
infecti
diseas
basi
chang
clinic
epidemiolog
trend
particip
wellcoordin
collabor
network
may
function
first
line
defenc
newli
emerg
virus
network
involv
syndrom
surveil
combin
routin
surveil
activ
known
pathogen
anim
human
identifi
earli
stage
emerg
viral
infect
would
otherwis
fli
radar
essenti
time
respons
ideal
could
even
abrog
viral
threat
altogeth
butcher
farmer
veterinarian
zoo
worker
popul
increas
suscept
inject
drug
user
immunocompromis
individu
addit
syndrom
viru
surveil
focu
domest
anim
well
wildlif
key
reservoir
speci
previous
shown
repres
immin
health
threat
human
like
domest
poultri
pig
rumin
well
wild
bird
rodent
bat
respect
effort
lead
identif
futur
viral
threat
allow
earli
detect
emerg
human
control
eventu
spread
combin
knowledg
molecular
basi
pathogen
transmiss
respect
speci
inform
may
even
allow
predict
virus
like
cross
speci
barrier
requir
evolutionari
transit
anim
viru
human
pathogen
despit
use
wide
rang
sensit
diagnost
assay
rel
larg
proport
patient
anim
suffer
appar
infecti
diseas
pathogen
detect
suggest
presenc
unidentifi
virus
human
anim
popul
pregenom
era
new
virus
first
identifi
anim
experi
viru
isol
tissu
cultur
standard
molecular
detect
method
nowaday
order
discov
isol
new
emerg
virus
crucial
develop
implement
set
novel
molecular
techniqu
appli
technolog
platform
increas
success
rate
find
new
virus
human
anim
may
may
associ
new
alreadi
identifi
diseas
entiti
besid
classic
continu
cell
cultur
mani
recent
discov
virus
fail
replic
sever
new
ex
vivo
cultur
system
develop
natur
viral
replic
circumst
may
best
mimick
infect
organ
cultur
surgeryderiv
byproduct
tissu
exampl
success
approach
human
rhinoviru
c
hrvc
recent
implic
upper
lower
respiratori
tract
infect
children
individu
chronic
respiratori
diseas
although
hrvc
discov
effort
propag
viru
cultur
fail
bochkov
cowork
employ
human
organ
cultur
sinu
mucosa
serial
propag
human
rhinoviru
c
ultim
allow
complet
fulllength
genom
sequenc
clone
likewis
ex
vivo
swine
respiratori
emerg
virus
viral
genom
aim
identif
character
emerg
reemerg
virus
requir
differ
disciplin
integr
respons
allow
virus
discov
potenti
pathogen
threat
effect
counter
enter
tract
cultur
use
studi
influenza
viru
infect
natur
target
cell
develop
pcr
novel
sequenc
techniqu
seen
enorm
increas
identif
character
viral
genom
lead
develop
new
speciesspecif
assay
routin
diagnost
surveil
anim
human
addit
gener
pcr
assay
pcr
assay
specif
broader
taxonom
rang
one
viru
speci
eg
whole
viru
genu
famili
develop
allow
identif
new
viru
speci
within
alreadi
known
viru
famili
method
comprehens
unbias
analysi
viral
preval
biolog
specimen
devis
use
long
oligonucleotid
dna
microarray
potenti
simultan
detect
hundr
virus
panvir
microarray
allow
detect
known
virus
also
discoveri
new
virus
suffici
relat
alreadi
known
permit
specif
hybrid
breakthrough
field
metagenom
farreach
effect
identif
character
newli
emerg
viral
pathogen
recognit
grow
number
diseas
attribut
unknown
caus
actual
caus
trigger
infecti
agent
viral
metagenom
assay
reli
sequenceindepend
amplif
nucleic
acid
clinic
sampl
combin
nextgener
sequenc
platform
bioinformat
tool
sequenc
analysi
rel
simpl
fast
allow
detect
new
virus
even
highli
diverg
alreadi
known
sinc
first
applic
metagenom
field
virolog
increasingli
appli
viru
discoveri
purpos
result
increas
relat
public
field
substanti
increas
identif
new
virus
develop
new
techniqu
identif
new
viru
complet
genom
character
done
matter
day
fraction
cost
compar
year
ago
unlik
howev
genomicsbas
tool
use
clinic
diagnost
set
within
next
decad
method
need
costeffect
highthroughput
format
requir
invest
bioinformat
tool
databas
data
manag
molecular
diagnostician
need
gain
experi
abil
interpret
data
gener
radic
differ
genomicsbas
techniqu
hurdl
regard
patient
privaci
issu
may
need
resolv
transit
genomicsbas
tool
research
set
clinic
one
step
beyond
viru
discoveri
initi
genom
character
viral
genom
integr
approach
determin
epidemiolog
pathogen
viru
diseas
caus
requir
order
develop
tailor
effect
intervent
contain
strategi
mani
factor
among
immun
statu
age
nutrit
statu
play
import
role
clinic
outcom
infect
underlin
import
studi
host
pathogen
paramet
integr
way
combat
viru
infect
comparison
close
relat
virus
differ
relat
host
speci
provid
crucial
inform
variou
host
pathway
involv
differ
outcom
diseas
perhap
best
exemplifi
simian
immunodefici
viru
siv
infect
differ
primat
host
speci
gener
nonhuman
primat
speci
natur
infect
siv
develop
aid
wherea
nonnatur
host
like
exampl
human
infect
hiv
develop
immunodefici
aid
genomicsbas
approach
delin
host
respons
infect
natur
nonnatur
host
reveal
nonnatur
host
higher
viral
load
immun
activ
loss
certain
tcell
subset
higher
product
interferona
respons
siv
infect
natur
host
thu
studi
key
interact
host
pathogen
may
unravel
possibl
develop
multitarget
therapi
design
limit
viru
replic
mitig
immun
patholog
transmiss
exampl
recent
import
zoonot
event
role
integr
approach
elucid
pathogenesi
order
combat
viral
infect
discuss
highli
pathogen
avian
influenza
viru
may
caus
infect
lower
respiratori
tract
sever
pneumonia
human
contrast
human
influenza
virus
import
caus
upper
respiratori
diseas
rare
caus
pneumonia
viral
attach
host
cell
critic
determin
infect
tropism
viru
studi
receptor
attach
human
influenza
virus
avian
influenza
viru
reveal
pattern
attach
respiratori
tract
coincid
well
differ
diseas
outcom
influenza
viru
primarili
attach
type
ii
pneumocyt
alveolar
macrophag
noncili
cuboid
epitheli
cell
termin
bronchiol
wherea
season
human
influenza
virus
attach
primarili
tracheal
bronchial
epithelium
type
pneumocyt
alveoli
essenti
human
season
influenza
virus
mainli
bind
upper
respiratori
tract
wherea
avian
influenza
virus
predilect
lower
respiratori
tract
pattern
receptor
attach
also
correl
mark
differ
effici
humantohuman
transmiss
influenza
virus
influenza
virus
display
notori
low
level
humantohuman
transmiss
concern
viru
could
acquir
molecular
characterist
would
allow
becom
readili
transmiss
human
initi
pandem
bind
prefer
ha
surfac
glycoprotein
influenza
viru
chang
avian
sialic
acid
receptor
human
sialic
acid
receptor
result
associ
chang
tropism
upper
respiratori
tract
studi
condit
would
inde
allow
influenza
viru
acquir
abil
aerosol
transmiss
vivo
influenza
viru
genet
modifi
studi
whether
viru
could
transmit
air
five
amino
acid
substitut
prove
consist
present
airbornetransmit
influenza
virus
ferret
collect
data
suggest
highli
pathogen
avian
influenza
virus
potenti
evolv
directli
way
allow
airborn
transmiss
mammal
without
reassort
intermedi
host
illustr
risk
virus
may
eventu
becom
pandem
human
next
step
perform
risk
assess
likelihood
viru
aris
spread
use
comput
simul
associ
laboratori
experi
ultim
allow
inform
decis
make
justifi
effort
pandem
prepared
highli
pathogen
avian
influenza
viru
recent
previous
unknown
coronaviru
hcovemc
isol
patient
present
acut
pneumonia
renal
failur
fatal
outcom
saudi
arabia
clinic
present
patient
remark
similar
caus
sar
coronaviru
sar
patient
outbreak
wherea
infect
caus
human
coronavirus
rel
mild
function
receptor
sar
coronaviru
human
angiotensinconvert
enzym
soon
establish
hcovemc
use
differ
receptor
fourteen
human
hcovemc
case
identifi
date
result
eight
fatal
respiratori
diseas
transmiss
chain
hcovemc
remain
unclear
could
explain
humantohuman
transmiss
well
repeat
introduct
reservoir
anim
host
complet
genom
viru
character
soon
discoveri
viru
basi
genet
related
hcovemc
bat
coronavirus
like
viru
emerg
bat
host
speci
switch
plausibl
light
recent
identif
dipeptidyl
peptidas
evolutionari
wellconserv
protein
function
receptor
hcovemc
abil
hcovemc
use
bat
function
receptor
identif
receptor
contribut
understand
pathogenesi
epidemiolog
hcovemc
may
facilit
develop
antivir
strategi
interestingli
sar
coronaviru
also
thought
origin
bat
recombin
two
bat
virus
result
bat
viru
supposedli
transmit
first
palm
civet
paguma
larvata
carnivor
subsequ
human
live
anim
market
southern
china
studi
pathogenesi
sar
coronaviru
reveal
cynomolgu
macaqu
macaca
fasciculari
show
lung
patholog
similar
natur
observ
human
adult
sar
upon
infect
use
combin
approach
anim
experi
immunohistochemistri
function
genom
shown
induct
earli
interferon
signal
may
critic
confer
protect
sar
coronaviru
notion
enforc
show
age
sar
coronavirusinfect
macaqu
show
sever
patholog
similar
viral
replic
level
associ
increas
differenti
gene
express
inflamm
reduc
type
interferon
express
compar
young
adult
macaqu
interestingli
also
human
clear
agerel
suscept
develop
clinic
symptom
sever
diseas
note
subsequ
therapeut
treatment
age
macaqu
type
interferon
reduc
patholog
age
sar
coronaviru
infect
macaqu
without
affect
viru
replic
level
suggest
prophylact
also
therapeut
treatment
pegyl
interferona
consid
antivir
treatment
note
howev
subsequ
studi
show
differ
nonhuman
primat
speci
develop
patholog
upon
sar
coronaviru
infect
distinct
acut
lung
injuri
pathway
taken
account
analyz
outcom
intervent
strategi
increas
threat
emerg
reemerg
viru
infect
human
anim
health
ask
time
effect
respons
counteract
viral
infect
recogn
result
format
quit
number
initi
focus
improv
surveil
viru
discoveri
effect
respons
manag
exampl
european
fund
seventh
framework
project
entitl
european
manag
platform
emerg
reemerg
infecti
diseas
entiti
emperi
contribut
effect
counter
potenti
public
health
threat
caus
new
emerg
infecti
diseas
europ
establish
power
network
capabl
structur
systemat
predict
identif
model
surveil
infecti
diseas
health
threat
pathogen
nation
fund
initi
netherland
virgo
consortium
focus
provid
infrastructur
viru
discoveri
progress
knowledg
virus
mechan
mutual
virushost
interact
feed
subsequ
develop
novel
intervent
diagnost
prognost
level
individu
patient
popul
european
fund
pathseek
consortium
set
disrupt
diagnost
technolog
pathogen
sequenc
platform
deliv
hour
possibl
drug
resist
mutat
well
data
nosocomi
infect
one
patient
sampl
one
singl
assay
anoth
european
fund
consortium
call
antigon
anticip
global
onset
novel
epidem
compar
relat
consortia
becom
increasingli
interlink
provid
intern
collabor
differ
expertis
area
allow
broad
rang
respons
mitig
potenti
effect
futur
infecti
threat
figur
quit
success
stori
alreadi
